Reproductive health care after transplantation

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1222-34. doi: 10.1016/j.bpobgyn.2014.09.002.

Abstract

Contraception, cervical cancer screening, human papillomavirus (HPV) vaccination, sexually transmitted infection (STI) screening, and menstrual disorders are issues that need to be addressed in all reproductive-aged women, including those with a history of solid organ transplantation. There are specific considerations that may alter routine care in this population. Due to teratogenic immunosuppressive medications, highly effective contraception is important to planning or appropriately timing pregnancy. Estrogen-containing methods (pill, patch, and ring) may be contraindicated. Immunosuppression is also a consideration when screening for and treating STIs including precancerous conditions of the cervix. This chapter will provide a framework to address the specific gynecologic needs of women with a history of solid organ transplantation.

MeSH terms

  • Adult
  • Contraception / methods
  • Female
  • Follow-Up Studies
  • Guidelines as Topic
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Incidence
  • Mass Screening / methods
  • Organ Transplantation*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage*
  • Pregnancy
  • Prevalence
  • Reproductive Health*
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / prevention & control*
  • United States / epidemiology
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / prevention & control*

Substances

  • Papillomavirus Vaccines